Search

Your search keyword '"Sasaki, Hikaru"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Sasaki, Hikaru" Remove constraint Author: "Sasaki, Hikaru" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
49 results on '"Sasaki, Hikaru"'

Search Results

3. Disturbance Injection under Partial Automation: Robust Imitation Learning for Long-horizon Tasks

4. Bayesian Disturbance Injection: Robust Imitation Learning of Flexible Policies for Robot Manipulation

8. Duality Cascades and Parallelotopes

9. Disturbance-Injected Robust Imitation Learning with Task Achievement

10. Gaussian Process Self-triggered Policy Search in Weakly Observable Environments

12. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence

16. Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.

18. A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors

20. 10001-ACT-1 A MULTICENTER EXPLORATORY PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT GLIOMA - THE SECOND REPORT

21. SURG-01. DIFFERENTIATION OF GLIOBLASTOMA AND MALIGNANT MENINGIOMA FROM NORMAL BRAIN BY TISSUE STIFFNESS UTILIZING MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY

24. コウカケイ ダイガクセイ ノ コミュニケーション ノ ケイジテキ ヘンカ ト メンタルヘルス ノ カンケイ

25. ニュウガク ショキ ノ ガクギョウ ヘノ ツマズキ カン オヨビ シンリテキ リスク ト セイシンテキ フケンコウ オヨビ ダイガクセイカツ ノ ジュウジツカン テイカ ノ ハッセイ リスク

26. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma

29. 初年次学生の修学に関するリスク特性と精神的不健康、大学不適応症状、不登校症状の発生リスクの関係;Relationships between risk characteristics related to study of university freshmen and the relative risk of mental illness, university maladaptation, and school refusal behavior

33. BOT-3 GENOME-WIDE ASSOCIATION STUDY OF INTRACRANIAL GERM CELL TUMORS: A COMMON DELETION ATBAK1 ATTENUATES THE ENHANCER ACTIVITY AND CONFERS RISK FOR THE BRAIN TUMORS IN CHILDREN ADOLESCENTS AND YOUNG ADULTS

34. LW-8 TREATMENT STRATEGY FOR OLIGODENDROGLIOMAS WITH NEOADJUVANT STRATEGY AND STAGED RESECTION UTILIZING THEIR CHEMOTHERAPEUTIC RESPONSIVENESS

35. MPC-1 IMMUNOHISTOLOGICAL COMPREHENSIVE ANALYSIS OF ANGIOGENIC FACTORS OTHER THAN VEGF IN GLIOBLASTOMAS IN RELATION TO THE USE OF BEVACIZUMAB

36. ACT-1 A PROSPECTIVE MULTICENTER PHASE I/IIA STUDY OF PREOPERATIVE NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED GLIOBLASTOMA

37. Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C

38. SURG-21. DEVELOPMENT OF MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY FOR IN SITU DIFFERENTIATION OF TUMOR TISSUE FROM NORMAL BRAIN DURING MICROSURGERY BY TISSUE STIFFNESS

39. Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired Comparison Between Newly Diagnosed and Recurrent Glioblastomas

42. Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.

48. [Meningioma].

49. [Glioblastoma That Does Not Improve with Standard Treatment: Standard and Personalized Treatment Making The Most of Limited Modalities].

Catalog

Books, media, physical & digital resources